NG
IDXX icon

Norden Group’s Idexx Laboratories IDXX Stock Holding History

Norden Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Sell
2,361
-1,497
-39% -$840K 0.1% 178
2026
Q1 		$2.17M Sell
3,858
-198
-5% -$127K 0.21% 98
2025
Q4 		$2.74M Buy
4,056
+199
+5% +$136K 0.27% 72
2025
Q3 		$2.46M Sell
3,857
-26
-0.7% -$15.8K 0.25% 79
2025
Q2 		$2.08M Buy
3,883
+3,313
+581% +$1.58M 0.23% 94
2025
Q1 		$239K Buy
+570
New +$248K 0.03% 483
2024
Q4 		– Sell
-586
Closed -$296K – 541
2024
Q3 		$296K Buy
586
+170
+41% +$82.6K 0.03% 401
2024
Q2 		$203K Buy
+416
New +$209K 0.04% 383

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Norden Group's IDXX Position: Q2 2026 in Review

Norden Group reduced its Idexx Laboratories (IDXX) stake by 39% in Q2 2026, selling an estimated $840K and leaving 2,361 shares worth $1.24M. The position accounts for 0.1% of the portfolio, ranked #178.

Norden Group first reported a position in IDXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.74M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Norden Group held 2,361 shares of Idexx Laboratories worth $1.24M as of Q2 2026.
  • Norden Group sold 1,497 Idexx Laboratories shares in Q2 2026, an estimated $840K.
  • Idexx Laboratories made up 0.1% of Norden Group's portfolio in Q2 2026, its #178 holding.
  • Norden Group first reported a position in Idexx Laboratories in Q2 2024 and has held it in 8 quarters since.
  • Norden Group's Idexx Laboratories position peaked at $2.74M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.